CDC42 and colorectal cancer: Analyses of human colorectal cancer specimens identified a high incidence of Cdc42 overexpression [18] and showed that presence of Cdc42 target proteins could be readily detected in tumors from human colorectal cancer patients, providing a screening tool for both enrolling patients in future clinical trials and evaluating the outcome of such trials.